Last reviewed · How we verify
ALL, High risk
At a glance
| Generic name | ALL, High risk |
|---|---|
| Sponsor | Jae Wook Lee |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure (NA)
- Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) (PHASE1)
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Immediate Restoration of a New Implant With High Primary Stability (NA)
- DEEP Substrate Mapping Versus Activation Mapping for VT (NA)
- Phase 2b Controlled Study of Dosing Techniques - Part B (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ALL, High risk CI brief — competitive landscape report
- ALL, High risk updates RSS · CI watch RSS
- Jae Wook Lee portfolio CI